Baird’s European Healthcare Team off to a Stellar Start in 2022
Coming off a record 2021 when the Heathcare team closed over 45 transactions, Baird’s Global Healthcare Investment Banking team is continuing its transaction momentum with a strong start to 2022. The team now includes over 40 investment bankers and continues to rapidly expand, especially in Europe.
Led by London based Managing Director, Andrew Nicholson, Baird has built a dedicated European Healthcare Investment Banking team of around 10 bankers. The team has also expanded its global focus on pharma services through the recent addition of Tom Cowap in London who focuses on pharma services and pharma tech. Baird’s growing team significantly strengthens its European healthcare coverage and cross-border capabilities.
It’s an exciting time for Baird’s European Healthcare team. Expanding this team has been and continues to be a key focus for Baird. The investment in people and our strong momentum in closing transactions is incredibly exciting and we are ever more strongly positioned to serve companies and investors in European healthcare.- Andrew Nicholson, Managing Director, Head of Healthcare Europe
Baird’s European Healthcare team has already closed four deals in the first few months of 2022 and expects to announce more deals in the coming months:
Connect with our team to learn more about these transactions. We welcome the opportunity to share more about Baird’s European Healthcare coverage and what to expect in 2022.
Contact Senior Members of Baird’s European Healthcare Team
+44 7740 958 426
+44 7552 342 477
+44 7860 272 598
Cowap has joined the firm as a Director on the Healthcare Team, further enhancing the business's European industry coverage.
Baird’s Women's Health & Wellness Showcase spotlights several trailblazing companies that are tackling the unique issues women face related to health, wellness and all-around wellbeing.